A new study published in the Journal of Bone and Mineral Research has found that smoking marijuana may help to heal broken bones more quickly.
Researchers at Tel Aviv University found that rats with broken bones healed more quickly when given cannabinoid, or CBD, the non-psychotropic compound in weed, and THC.
The study, published in the Journal of Bone and Mineral Research on Thursday found that the bones not only healed quicker, but were also stronger and more resilient against a repeated fracture, meaning the bones treated with marijuana were much less likely to break again.
The scientists behind the research believe that this is due to a connection between cannabinoid receptors in the human body and the stimulation of bone growth.
Dr. Yankel Gabet of Tel Aviv’s Bone Research Laboratory presented findings that show that cannabidiol (CBD), a non-psychoactive chemical found in marijuana, may have therapeutic qualities in the mending of fractured bones. CBD can be separated from tetrahydrocannabinol (THC), the component of marijuana commonly attributed to cause the altered state produced by taking the substance.
Because of the ability of the chemical to able to have positive outcomes for the healing of broken bones, there will undoubtedly be a continued effort to prove the effectiveness of CBD. Medical marijuana has also been shown to be effective for a range of other ailments. One of the most recently discovered is a possible positive influence on Alzheimer’s disease. A study published in the Journal of Alzheimer’s Disease presented findings indicative of a use for the substance to treat the disease, previously reported Inquisitr.
Over 100 Scientific Studies Agree Cannabis Annihilates Cancer
An interesting article from the website WakeUpWorld.com. A lot of links to government and other studies. Lots of scientific research stuff…Take a look.
Note: There is so much information here and there are a lot of links to many informative sites. Click here to open in a new page so you don’t lose KomornLaw.com site…or just add us to your favorites.
Considering that up until about 85 years ago, cannabis oil was used around the world to treat a variety of diseases, including cancer, it is not surprising that the phasing out of cannabis to treat illness coincided with the rise of pharmaceutical companies.
Rick Simpson, a medical marijuana activist, is on a crusade to help others heal. He regards cannabis as the most medicinally active plant on the face of the earth, and shared this apparent miracle with others — completely free of charge. He now has thousands of testimonials from those who were healed from ‘incurable’ disease to back up his claims ~ that cannabis annihilates cancer.
For the naysayers out there who are still not convinced about the effectiveness of cannabis for curing cancer, the astounding healing attributes of the plant are well documented by a wealth of peer-reviewed studies.
Traditional medicinal plant backed by modern medicine
Breast cancer
A study in Molecular Cancer Therapeutics explored the relationship between the use of cannabidiol (CBD) and the subsequent down regulation of breast cancer tumor aggressiveness. The researchers concluded that CBD represents the first nontoxic agent to decrease the aggressiveness of metastic breast cancer cells in vivo.
Furthermore, the journal PLoS One reports further evidence of how cannabinoids modulate breast cancer tumor growth and metastasis by inhibiting specific receptors.
“Studies on epithelial cells have shown that cannabinoids exert antiproliferative, antimetastatic and apoptotic effects as well as reducing cytokine release and promoting wound healing. In vivo, cannabinoids – via direct or indirect activation of CB(1) and/or CB(2) receptors – exert protective effects in well-established models of intestinal inflammation and colon cancer.”
The team concluded that the administration of cannabinoids “may be a promising strategy to counteract intestinal inflammation and colon cancer.”
Cannabis was shown to induce cytotoxicity in leukemia cell lines, according the the journal Blood:
“We have shown that THC is a potent inducer of apoptosis, even at 1 x IC(50) (inhibitory concentration 50%) concentrations and as early as 6 hours after exposure to the drug. These effects were seen in leukemic cell lines (CEM, HEL-92, and HL60) as well as in peripheral blood mononuclear cells.”
It also did not appear that the cannabis was simply aiding other chemo drugs — it was independently bringing about results with the active compound THC responsible for cancer cell death in vitro.
Likewise, a study in the Molecular Pharmacology Journal found that non psychoactive cannabidiol dramatically induced apoptosis (cell death) in leukemia cells. “Together, the results from this study reveal that cannabidiol, acting through CB2 and regulation of Nox4 and p22(phox) expression, may be a novel and highly selective treatment for leukemia.”
Research published in the paper Prostaglandins, Leukotrienes and Essential Fatty Acids found that cannabinoid compounds play a vital role in modulating the immune system to improve the outcome of a cancer diagnosis. In short, the team believes “[t]he experimental evidence reviewed in this article argues in favor of the therapeutic potential of these compounds in immune disorders and cancer.”
Moreover, the study Cannabinoids and the immune system confirms that cannabimimetic agents have substantial effects on natural killer cells, thereby providing therapeutic usefulness in reducing tumor growth and the induction of apoptosis. Therefore, cannabis demonstrates a “subtle but significant role in the regulation of immunity and that this role can eventually be exploited in the management of human disease.”
Cervical cancer
Uterine cervical cancer cells are significantly influenced by cannabis as well. Published in Gynecologic Oncology, the research team discovered that the compound induced apoptosis in cervical carcinoma (CxCa) cell lines.
Melanoma
The most deadly form of skin cancer, melanoma has relatively few options of treatment beyond prevention and early detection. With this in mind, the findings of the study Cannabinoid receptors as novel targets for the treatment of melanoma are of particular note. In animal tests, cannabinoids encouraged cancer cell death, while decreasing growth, proliferation and metastasis of melanoma cells.
“Local administration of [cannabinoids] induced a considerable growth inhibition of malignant tumors generated by inoculation of epidermal tumor cells into nude mice. Cannabinoid-treated tumors showed an increased number of apoptotic cells. This was accompanied by impairment of tumor vascularization, as determined by altered blood vessel morphology and decreased expression of proangiogenic factors (VEGF, placental growth factor, and angiopoietin 2). … These results support a new therapeutic approach for the treatment of skin tumors.”
These are just a few examples — among hundreds — that demonstrate the effectiveness of cannabis in eradicating cancer without adverse side-effects. Additionally, the following documentary explores the history and modern uses of cannabis to heal serious diseases such as cancer, AIDS, Crohn’s disease & more:
Medical Cannabis and Its Impact on Human Health: a Cannabis Documentary
Scientific Studies from the National Institute of Health
If you’re still in doubt regarding the effectiveness of cannabis for healing cancer, have a look at these 100+ scientific studies from the National Institute of Health:
Just had to place this article as it was without blog banter. Go ahead and read it.
BY PAUL ARMENTANO · MON MAR 02, 2015
Allegations from anti-pot proponents that cannabis use by adults causes serious harms are unwarranted and unproven. So says one of the nation’s leading marijuana researchers. Speaking recently to the American Association for the Advancement of Science (AAAS), Dr. Igor Grant acknowledged, “There is no evidence for long-term damaging effects in adults.” He ought to know. Over his professional tenure, Grant has authored several peer-review journal articles specific to the health effects of cannabis, including a 2003 report which concluded that the long-term heavy use of pot was not associated with the “substantial, systematic, and detrimental effect of cannabis use on neuropsychological performance.” Grant also served as the director of the University of California Center for Medicinal Cannabis Research, during which time he oversaw the completion of a number of FDA-approved clinical trials assessing the safety and efficacy of whole-smoked marijuana. In 2012, he co-authored a summary of these trials for the scientific journal Open Neurology.
“Based on evidence currently available the Schedule I classification is not tenable; it is not accurate that cannabis has no medical value, or that information on safety is lacking,” the article concluded. Speaking at this year’s AAAS meeting, Grant said that smoking cannabis long-term is associated with bronchitis. But he cautioned that purported links between cannabis and the onset of psychiatric disorders like schizophrenia have yet to be established. He also warned that allegations that cannabis harms the brain “are very weak at the moment.” Grant further acknowledged that the present Schedule I classification of the plant is inappropriate and severely hampers investigators from studying its effects.
“In the U.S. there are certainly a number of hurdles and processes one has to go through, and I think this does inhibit ordinary investigators who don’t have the means or the knowledge or the staying power to get through the system,” he said. On February 11, a federal judge for the Ninth Circuit heard closing arguments in a motion challenging the constitutionality of marijuana’s Schedule I classification. The case marks the first time since 1973 that a federal judge has weighed evidence in regard to whether there exists a “rational basis” for the government to maintain the plant’s prohibitive status The judge is anticipated to rule on the matter by mid-March.
